Cargando…
MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
PURPOSE: Despite the established role of O6-methyl-guanine-DNA methyltransferase (MGMT) as a marker for temozolomide response, consensus of the most reliable method to assess MGMT expression in pituitary adenomas is still missing. Currently, immunohistochemistry (IHC) assessment of formaldehyde fixe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942339/ https://www.ncbi.nlm.nih.gov/pubmed/29344904 http://dx.doi.org/10.1007/s11102-018-0862-x |
_version_ | 1783321448779087872 |
---|---|
author | Micko, Alexander S. G. Höftberger, Romana Wöhrer, Adelheid Millesi, Matthias Knosp, Engelbert Wolfsberger, Stefan |
author_facet | Micko, Alexander S. G. Höftberger, Romana Wöhrer, Adelheid Millesi, Matthias Knosp, Engelbert Wolfsberger, Stefan |
author_sort | Micko, Alexander S. G. |
collection | PubMed |
description | PURPOSE: Despite the established role of O6-methyl-guanine-DNA methyltransferase (MGMT) as a marker for temozolomide response, consensus of the most reliable method to assess MGMT expression in pituitary adenomas is still missing. Currently, immunohistochemistry (IHC) assessment of formaldehyde fixed tissue samples is most widely used in a semiquantitative description. As formaldehyde fails to completely preserve nucleic acids, RCL2, an alcohol-based formaldehyde-free fixative, has been proposed as a more reliable alternative in terms of cell stability. Furthermore, as the current method of IHC is semiquantitative and observer-dependent, pyrosequencing, an objective tool to evaluate the methylation status of the MGMT promoter, has emerged as a reliable and accurate alternative. The aim of this study was to validate the current IHC method for assessment of MGMT protein expression in pituitary adenomas. METHODS: The tissue samples of 8 macroadenomas with positive IHC MGMT expression (> 50%) were investigated: first, we compared the time dependent stability of MGMT protein expression after pituitary adenoma removal between formaldehyde vs. RCL2. Then, we compared positive IHC MGMT expression with methylated promoter status using pyrosequencing. RESULTS: In the first 12 h after adenoma removal, tissue samples remained MGMT positive in significantly more samples when fixated with formaldehyde than with RCL2, respectively (96 vs. 81%, p = 0.025). CONCLUSION: Our data confirm that the current method using formaldehyde tissue fixation and IHC reveals stable and reliable results of MGMT assessment in pituitary adenomas. |
format | Online Article Text |
id | pubmed-5942339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-59423392018-05-14 MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals Micko, Alexander S. G. Höftberger, Romana Wöhrer, Adelheid Millesi, Matthias Knosp, Engelbert Wolfsberger, Stefan Pituitary Article PURPOSE: Despite the established role of O6-methyl-guanine-DNA methyltransferase (MGMT) as a marker for temozolomide response, consensus of the most reliable method to assess MGMT expression in pituitary adenomas is still missing. Currently, immunohistochemistry (IHC) assessment of formaldehyde fixed tissue samples is most widely used in a semiquantitative description. As formaldehyde fails to completely preserve nucleic acids, RCL2, an alcohol-based formaldehyde-free fixative, has been proposed as a more reliable alternative in terms of cell stability. Furthermore, as the current method of IHC is semiquantitative and observer-dependent, pyrosequencing, an objective tool to evaluate the methylation status of the MGMT promoter, has emerged as a reliable and accurate alternative. The aim of this study was to validate the current IHC method for assessment of MGMT protein expression in pituitary adenomas. METHODS: The tissue samples of 8 macroadenomas with positive IHC MGMT expression (> 50%) were investigated: first, we compared the time dependent stability of MGMT protein expression after pituitary adenoma removal between formaldehyde vs. RCL2. Then, we compared positive IHC MGMT expression with methylated promoter status using pyrosequencing. RESULTS: In the first 12 h after adenoma removal, tissue samples remained MGMT positive in significantly more samples when fixated with formaldehyde than with RCL2, respectively (96 vs. 81%, p = 0.025). CONCLUSION: Our data confirm that the current method using formaldehyde tissue fixation and IHC reveals stable and reliable results of MGMT assessment in pituitary adenomas. Springer US 2018-01-17 2018 /pmc/articles/PMC5942339/ /pubmed/29344904 http://dx.doi.org/10.1007/s11102-018-0862-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Micko, Alexander S. G. Höftberger, Romana Wöhrer, Adelheid Millesi, Matthias Knosp, Engelbert Wolfsberger, Stefan MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title | MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title_full | MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title_fullStr | MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title_full_unstemmed | MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title_short | MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
title_sort | mgmt assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942339/ https://www.ncbi.nlm.nih.gov/pubmed/29344904 http://dx.doi.org/10.1007/s11102-018-0862-x |
work_keys_str_mv | AT mickoalexandersg mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals AT hoftbergerromana mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals AT wohreradelheid mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals AT millesimatthias mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals AT knospengelbert mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals AT wolfsbergerstefan mgmtassessmentinpituitaryadenomascomparisonofdifferentimmunohistochemistryfixationchemicals |